Repligen | RGEN - 贸易债权人



金融业
股票价格
USD
资产
USD 2.95B
现金及等价物
USD 606.78M
销售成本
USD 94.09M
流动资产
USD 1.2B
流动负债
USD 132.66M
债务
USD 690.94M
EBIT
USD 21.13M
EBITDA
USD 43.77M
员工
1.78K
EPS每股收益
USD 0.54
股本和储备
USD 2.11B
销售毛利
USD 110.04M
债务利息支出
USD 5.66M
利息收入
USD 7.31M
贷款资金
USD 551.05M
市值
USD 9.28B
净收入
USD 5.01M
营业费用
USD 183M
营业利润
USD 21.13M
普通股股本
USD 56.43M
PE价格收益
105.09
税前利润
USD 14.15M
销售收入
USD 204M
销售和管理费用
USD 76.62M
股票
USD 186.6M
贸易债权人
USD 33.23M
应收帐款人
USD 157.71M


贸易债权人 更改 日
Agilent USD 615M 13M 2026-03
Align Technology USD 109.84M 13.88M 2026-06
Bio Techne USD 95.6M 3.97M 2026-03
BioMarin Pharmaceutical USD 913.67M 120.52M 2026-06
Bristol-Myers Squibb USD 4.16B 76M 2026-06
Bruker USD 200.2M 68.9M 2026-06
Charles River Laboratories USD 140.98M 7.03M 2026-06
Danaher USD 2.07B 282M 2026-06
Dentsply International USD 260M 1000K 2026-06
General Electric Aerospace USD 10.82B 139M 2026-06
Henry Schein USD 1.14B 92M 2026-06
Illumina USD 230M 12M 2026-06
IQVIA Holdings USD 3.61B 31M 2026-06
Mettler Toledo International USD 229.8M 1.08M 2026-06
Myriad Genetics USD 30.4M 2.2M 2026-06
OraSure Technologies USD 8.4M 2.23M 2026-06
Pacific Biosciences Of California USD 19.22M 5.61M 2026-06
Pfizer USD 4.58B 75M 2026-06
Repligen USD 33.23M 1.42M 2026-06
Revvity USD 165.74M 3.94M 2026-06
Standard Biotools USD 8.01M 2.6M 2026-03
Thermo Fisher Scientific USD 3.34B 278M 2026-03
Waters USD 602M 498.22M 2026-03
West Pharmaceutical Services USD 252.7M 400K 2026-06